Baxter International Inc. BAX has entered into a definitive
agreement to acquire Gambro AB, a privately held dialysis product
company based in Lund, Sweden, for total consideration of 26.5 billion
SEK (approximately $4.0 billion USD at current exchange rates). Gambro
is a global medical technology company focused on developing,
manufacturing and supplying dialysis products and therapies for patients
with acute or chronic kidney disease. The acquisition gives Baxter a
comprehensive dialysis product portfolio, complements Baxter's global
home dialysis offerings, and positions the company to better meet the
evolving needs of the large and growing dialysis market.
''Baxter has a legacy of innovation in dialysis, including the
development of peritoneal dialysis for the treatment of
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in